Entos Revenue and Competitors

Location

$53M

Total Funding

Estimated Revenue & Valuation

  • Entos's estimated annual revenue is currently $7.8M per year.(i)
  • Entos's estimated revenue per employee is $126,150
  • Entos's total funding is $53M.

Employee Data

  • Entos has 62 Employees.(i)
  • Entos grew their employee count by 0% last year.

Entos's People

NameTitleEmail/Phone
1
Co-founder and CEOReveal Email/Phone
2
Cofounder and CTOReveal Email/Phone
3
VP Analytical TechnologiesReveal Email/Phone
4
VP, Head ChemistryReveal Email/Phone
5
SVP, Business DevelopmentReveal Email/Phone
6
VP, BiologyReveal Email/Phone
7
VP, FinanceReveal Email/Phone
8
Director, BiologyReveal Email/Phone
9
Chief Scientific OfficerReveal Email/Phone
10
Director, Finance And OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.9M294%N/AN/A
#2
$43.4M2728%N/AN/A
#3
$14.1M9711%N/AN/A
#4
$1460M82917%$1.1BN/A
#5
$310M152720%N/AN/A
#6
$194.1M956-5%N/AN/A
#7
$223.9M1080-33%$101.6MN/A
#8
$581.3M27089%$253.1MN/A
#9
$716.2M35282%N/AN/A
#10
$801.4M394852%N/AN/A
Add Company

What Is Entos?

Entos drives chemical and biological innovation through thousand-fold speed ups in molecular prediction with transformative improvements in accuracy. Contact us to learn more about our software and machine-learning solutions.

keywords:N/A

$53M

Total Funding

62

Number of Employees

$7.8M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Entos News

2022-03-30 - Novel systems for realising the promise of DNA vaccines and ...

Dr John Lewis, CEO of Entos Pharmaceuticals, outlines how an innovative proteolipid platform could enable a new class of DNA-based vaccines...

2022-03-22 - Entos Pharmaceuticals Announces Senior Leadership ...

Steve Chen brings over 20 years of academic research and pharmaceutical biotechnology experience across multiple therapeutic areas to Entos. He...

2021-07-14 - Entos Raises $53 Million Series A Round Led by Coatue and Catalio

Entos, Inc (“Entos” or “the Company”), the creator of a cutting-edge platform combining AI-driven technology and automated synthetic development to design small-molecule therapeutics, today announced the closing of a $53 million Series A financing round led by Coatue, a leading technology invest ...

2021-07-14 - Entos Raises $53M in Series A Funding

Entos, Inc., a San Diego, CA-based creator of a platform combining AI-driven technology and automated synthetic development to design small-molecule therapeutics, closed a $53m Series A financing. The round was led by Coatue and Catalio Capital Management, with participation from OrbiMed and Se ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12.3M62-22%$39.1M
#2
$8.4M629%N/A
#3
$11.4M627%N/A
#4
$8.9M62-7%N/A
#5
$15.1M627%N/A